Genomize
PrivateMomentum
Top 10%
of companies Caplight tracks
Company Overview
Genomize is a healthtech company that provides a bioinformatics platform designed for genomic data analysis.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Healthcare Analytics, Precision Medicine, Medical AI, Platform-as-a-Service
Business Model
B2B
Customer Profile
Subscription SaaS, Usage-Based SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Genomize Comparables
Compare Genomize with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Geneyx | 91% | |
| Euformatics | 87% | |
| SeqOne | 83% |
Genomize Funding Rounds
Historical fundraising activity
Genomize Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| ScaleX Ventures | Angel |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 27, 2026
Grew 18% QoQ, from 17 to 20 employees.
- Jul 25, 2026
Monthly visitors increased 291% MoM, reaching 2.7K.
Genomize Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Genomize's valuation, stock price, and market status.
Is Genomize a public or private company?
Genomize is a private company.
What is the current stock price of Genomize?
Genomize is a private company with no public stock price. No recent secondary market data is available.
How much is Genomize worth (valuation)?
Valuation information for Genomize is not publicly available.
Can I buy Genomize stock?
Genomize shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Genomize's last funding round?
Funding round information for Genomize is not publicly available.
Who are the main investors in Genomize?
Key investors in Genomize include ScaleX Ventures.
Will Genomize IPO soon?
No public IPO plans have been announced for Genomize.
How can I track Genomize secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Genomize's secondary market activity and sign up for updates.